Keeping You Connected

The SCCMA keeps you up to date on the latest news,
policy developments, and events

Local News

rss

HEALTH ADVISORY: BENZATHINE PENICILLIN G SHORTAGE (P2)

The U.S. Food and Drug Administration (FDA) has announced a shortage of long-acting penicillin G benzathine injectable suspension products (Bicillin L-A), with an estimated recovery not before spring of 2024. Per the FDA, this drug shortage is due to an increased demand for the drug. Given the high rates of syphilis in California and in Santa Clara County, this is of significant concern.   Bicillin L-A remains the only acceptable treatment for pregnant people infected with or exposed to syphilis and should be prioritized for this population to prevent the harmful effects of congenital syphilis, including premature birth, ...